$1.50
$-0.01 (-0.66%)
End-of-day quote: 05/24/2024
NasdaqCM:BBLG
Bone Biologics Annual Report
| Year | Year | 2022 | 2021 | |||
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-3.23 | $-31.20 | $-84.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | ||
| Sha. | Shares |
|
0.06m | 10.35m | ||
| OCF | Operating Cash Flow |
|
$-3.57M | $-1.23M | ||
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | ||
| FCFS | Free Cash Flow Per Share |
|
$-74.94 | $-0.12 |
